Reuters Health Report

Click to View in Browser 04/2/2014 Young male smokers may raise obesity risk in their future sons LONDON (Reuters) - Men who start smoking before the age of 11 risk having sons who are overweight, British researchers have found, adding to evidence that lifestyle factors even in childhood can affect the health of future offspring. Fukushima meltdown unlikely to lead to large number of cancers: U.N. scientists VIENNA (Reuters) - Japan's Fukushima nuclear disaster is unlikely to lead to a large number of people developing cancer like after Chernobyl in 1986, even though the most exposed children may face an increased risk, U.N. scientists said on Wednesday. Donors commit $240 million to fight neglected tropical diseases (Reuters) - Bill Gates, the World Bank and other donors are stepping up efforts to fight neglected tropical diseases in Africa and other low-income regions with a $240 million injection of new funding. Anxiety, depression 'highly prevalent' in football, says study BERNE (Reuters) - More than one quarter of professional footballers who took part in a survey conducted by the world players' union said they suffered from depression or anxiety, FIFPro said Wednesday. MannKind soars as FDA panel backs its inhaled insulin product (Reuters) - MannKind Corp's shares doubled on Wednesday, after an advisory committee to the U.S. health regulator recommended approval of the drug developer's inhaled insulin treatment. GlaxoSmithKline throws in towel on lung cancer vaccine trial LONDON (Reuters) - GlaxoSmithKline Plc (GSK) has stopped a high-profile clinical trial using a novel vaccine to fight lung cancer after deciding it will not be possible to find a sub-group of patients who might benefit. South African HIV prevalence rises on soaring new infections JOHANNESBURG (Reuters) - The prevalence of HIV/AIDS in South Africa is rising due to the world's fastest growth in new infections and a higher patient survival rate, according to a new health study. Stallergenes wins U.S. go-ahead for Oralair allergy pill CHICAGO/PARIS (Reuters) - France's Stallergenes has received U.S. regulatory approval to sell the first immunotherapy pill against grass allergies in the world's biggest pharmaceutical market, sending its shares up 6 percent on Wednesday. Obamacare enrollment exceeds seven million target despite setback WASHINGTON (Reuters) - President Barack Obama's national healthcare program signed up more than 7 million people by the end of March, the president said on Tuesday, notching a rare victory after a months-long, glitch-filled rollout of the law. Obamacare has thousands of 'Cinderella' would-be enrollees WASHINGTON (Reuters) - Call them the "Cinderella customers" - those who tried to enroll in coverage under President Barack Obama's healthcare law but were unable to do so when midnight tolled on April 1. Related Video Titanium golf clubs a fire risk: scientists March's end roars like a lion in North Dakota The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend